Cell Reprogramming & Therapeutics

Cell Reprogramming & Therapeutics

Biotechnology, 4404 S 113th St, Milwaukee, Wisconsin, 53228, United States, 1-10 Employees

cellrtherapeutics.com

  • LinkedIn

phone no Phone Number: 41********

Who is CELL REPROGRAMMING & THERAPEUTICS

Cell Reprogramming & Therapeutics LLC is focused on the development and commercialization of cell-based technologies to target diseases of the central nervous system. The companys program...

Read More

map
  • 4404 S 113th St, Milwaukee, Wisconsin, 53228, United States Headquarters: 4404 S 113th St, Milwaukee, Wisconsin, 53228, United States
  • 2013 Date Founded: 2013
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: Under $1 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2834

checked-icon Does something look wrong? Fix it. | View contact records from CELL REPROGRAMMING & THERAPEUTICS

Cell Reprogramming & Therapeutics Org Chart and Mapping

Employees

Arshak Alexanian

Chief Scientific Officer

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Cell Reprogramming & Therapeutics

Answer: Cell Reprogramming & Therapeutics's headquarters are located at 4404 S 113th St, Milwaukee, Wisconsin, 53228, United States

Answer: Cell Reprogramming & Therapeutics's phone number is 41********

Answer: Cell Reprogramming & Therapeutics's official website is https://cellrtherapeutics.com

Answer: Cell Reprogramming & Therapeutics's revenue is Under $1 Million

Answer: Cell Reprogramming & Therapeutics's SIC: 2834

Answer: Cell Reprogramming & Therapeutics has 1-10 employees

Answer: Cell Reprogramming & Therapeutics is in Biotechnology

Answer: Cell Reprogramming & Therapeutics contact info: Phone number: 41******** Website: https://cellrtherapeutics.com

Answer: Cell Reprogramming & Therapeutics LLC is focused on the development and commercialization of cell-based technologies to target diseases of the central nervous system. The companys programs aim to develop cellular models and therapeutics for neurological disorders such as Brain and Spinal cord injuries, Stroke, Parkinson's, Alzheimer's, Amyotrophic Lateral Sclerosis, Huntington's and brain cancers.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access